SEI Investments
VRDN icon

SEI Investments’s Viridian Therapeutics VRDN Stock Holding History

SEI Investments’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Buy
65,777
+35,459
+117% +$1.05M ﹤0.01% 2226
2025
Q4 		$943K Buy
30,318
+18,762
+162% +$515K ﹤0.01% 2208
2025
Q3 		$249K Buy
11,556
+1,046
+10% +$18.9K ﹤0.01% 2535
2025
Q2 		$147K Buy
+10,510
New +$143K ﹤0.01% 2631
2023
Q3 		– Sell
-9,934
Closed -$236K – 2700
2023
Q2 		$236K Sell
9,934
-27,412
-73% -$703K ﹤0.01% 2419
2023
Q1 		$950K Buy
37,346
+18,410
+97% +$590K ﹤0.01% 1892
2022
Q4 		$553K Buy
+18,936
New +$436K ﹤0.01% 1971
2018
Q3 		– Sell
-93
Closed -$9K – 3452
2018
Q2 		$9K Hold
93
– – ﹤0.01% 3039
2018
Q1 		$10K Buy
+93
New +$10.1K ﹤0.01% 2883

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return